The utility of amylase and lipase as reliable predictive markers for functioning renal graft

Annals of Transplantation

Volumn 17, Issue 3, 2012, Pages 77-84

  Yilmaz, Ugur Eser ^a   Yilmaz, Nevin ^b   Titiz, Izzet ^c   Basaranoglu, Metin ^b   Tarcin, Orhan ^d  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^b MUGLA SITKI KOCMAN UNIVERSITY   (Turkey)

^c GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

^d Acibadem Hospital   (Turkey)

Author keywords

Amylase; Graft dysfunction; Kidney transplant; Lipase

Indexed keywords

AMYLASE; BIOLOGICAL MARKER; CREATININE; TRIACYLGLYCEROL LIPASE;

ACUTE GRAFT REJECTION; AGED; AMYLASE BLOOD LEVEL; ARTICLE; CHILD; CONTROLLED STUDY; CREATININE CLEARANCE; FEMALE; GRAFT FAILURE; GRAFT RECIPIENT; HUMAN; KIDNEY FAILURE; KIDNEY GRAFT; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PROTEINURIA; RENAL GRAFT DYSFUNCTION; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; TRIACYLGLYCEROL LIPASE BLOOD LEVEL;

EID: 84868713184     PISSN: 14259524     EISSN: None     Source Type: Journal    
DOI: 10.12659/aot.883461     Document Type: Article

References (29)

1. Sahadevan M, Kasiske BL: Long-Term post transplant management and complications. In: Danovitch GM (ed.), Handbook of Kidney Transplantation, Lippincott Williams &Wilkins, Philadelphia; 2005; 147
2. Hariharan S, Mcbride SA, Cherikh WS et al: Post-transplant renal function in the first year predicts long-term kidney transplant survival. Kidney International, 2002; 62: 311-18
3. Fresnedo FG, Rodrigo E, DeFrancisco AL et al: Change in Serum Creatinine Levels between 6 and 12 Months and Kidney Graft Survival: Influence of Proteinuria. Transplant Proceedings, 2005; 37: 1433-34
4. Caban A, Brudzinski G, Oczkowicz G et al: Factors determining chances in concentrations of pro-inflamatory markers in blood serum in the initial period after kidney transplantation from dead donor. Ann Transplant, 2009; 14: 10-13
5. Halawa A: The early diagnosis of acute renal graft dysfunction: a challenge we face. The role of novel biomarkers. Ann Transplant, 2011; 16: 90-98
6. Kloda K, Domanski L, Pawlik A et al: Effect of the ICAM1 and VCAM1 gene polymorphisms on delayed graft function and acute kidney allograft rejection. Ann Transplant, 2010; 15: 15-20
7. Grzelak P, Szymczyk K, Strzelczyk J et al: Perfusion of kidney graft pyramids and cortex in contras-enhanced ultrasonography in the determination of the cause of delayed graft function. Ann Transplant, 2011; 16: 48-53
8. Mathew A, Chiemprabha AF, Donelson S: Hyperamylasemia. http://emedicine.medscape.com/article/186389-overview 2009
9. Pieper BC, Strocchi AL: Where does serum amylase come from and where does it go? Gastroenterol Clin North Am, 1990; (4): 793-810
10. Ravel R: Clinical Laboratory Medicine, 6th ed, Mosby, Missouri, 1995; 447-49
11. Tietz NW, Shuey DF: Lipase in serum-the Elusive Enzyme: An overview. Clin Chem, 1993; (5): 746-56
12. Waller SI, Ralston AJ: The hourly rate of urinary amylase excretion, serum amylase, and serum lipase. Part I. In control subjects and patients with renal disease. Gut, 1971; 12: 878-83
13. Agarwal N, Pitchumoni CS, Sivaprasad AV: Evaluating tests for acute pancreatitis. Am J Gastroenterol, 1990; 85(4): 356-66
14. Malfertheiner P, Kemmer TP: Clinical picture and diagnosis of acute pancreatitis. Hepatogastroenterology. 1991; 38(2): 97-100
15. Manjuck J, Zein J, Carpati C, Astiz M: Clinical significance of increased lipase levels on admission to the ICU. Chest, 2005; 127: 246-50
16. Rattner DW, Gu ZY, Vlahakes GJ, Warshaw AL: Hyperamylasemia after cardiac surgery. Incidence, significance, and management. Ann Surg, 1989; 209: 273-83
17. Penn I, Durst AL, Machado M et al: Acute pancreatitis and hyperamylasemia in renal homograft recipients. Arch Surg, 1972; (105): 167-72
18. Frick TW, Fryd DS, Sutherland DE et al: Hypercalcemia associated with pancreatitis and hyperamylasemia in renal transplant recipients: Data from the Minnesota randomized trial of cyclosporine versus antilymphoblast azathioprine. Am J Surg, 1987; (154): 487-89
19. Johnson WC, Nabseth DC: Pancreatitis in renal transplantation. Ann Surg, 1970; 171: 309-14
20. Tagagi H, Yasue M, Morimoto T et al: Asymtomatictransienthyperamylasemia after a large intravenous dose of steroid hormone. Am J Surg, 1977; 133: 322-25
21. Dardamanis MA, Elisaf MS, Vasakos SA et al: alpha-Amylase and isoamylase levels in renal transplant recipients compared touremicpatients. Ren Fail, 1995; (17): 715-19
22. Frederickson A, Jacobson G: Influence of renal function on the urinary excretion of amylase: An experimental study in the rat. Scandinavian J Clini Lab Invest, 1974; 33: 313-21
23. Johnson SG, Ellis CJ, Levitt MD: Mechanism of increased renal clearance of amylase/creatinine in acute pancreatitis. N Engl J Med, 1976; 295: 1214-17
24. Keogh JB, McGeeney KF, Drury MI et al: Renal clearance of pancreatic and salivary amylase relative to creatinine in patients with chronic renal insufficiency. Gut, 1978; 19: 1125-30
25. Jiang CF, Ng KW, Tan SW et al: Serum level of amylase and lipase in various stages of chronic renal insufficiency. Zhonghua Yi Xue Za Zhi (Taipei), 2002; (2): 49-54 (abstract)
26. Colen MJ, Ansher AF, Chapman AB et al: Serum amylase in patients with renal insufficiency and renal failure. Am J Gastroenterology, 1990; 85: 1377-80
27. Ventrucci M, Campieri C, Di Stefano M et al: Alterations of exocrine pancreas in end-stage renal disease. Do they reflect a clinically relevant uremic pancreopathy? Dig Dis Sci, 1995; 40: 2576-81
28. Caruana RJ, Altman R, Fowler B et al: Correlates of amylase and lipase levels in chronic dialysis patients. Int J Artif Organs, 1988; 11: 454-58
29. Junge W: The role of the kidney in the elimination of pancreatic lipase and amylase from blood. J Clin Chem Clin Biochem, 1985; 23: 387-92